Aclaris Therapeutics is a clinical-stage biopharmaceutical company based in Pennsylvania that develops small-molecule drugs for dermatological and immune-related conditions. Its work has focused on topical treatments for skin disorders, including seborrheic keratosis and hair loss, as well as kinase inhibitor programmes aimed at inflammatory disease. The company's customers and partners are primarily in the medical and pharmaceutical field, where it advances drug candidates through clinical testing rather than selling finished consumer products.
The shares are listed on the London Stock Exchange in UK under the code 0H8T, and the price on this page is in US dollars (USD). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Weak price profile
Ranks #3368 of 3788 on the London Stock Exchange · confidence Medium
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for UK yet.
TrendWeak
40/100
Below its long-term averages and far from its highs.
See the numbers →
Above 200-day average-15.3%
From 52-week high-41.9%
MomentumWeak
16/100
Lagging most stocks on this exchange.
See the numbers →
3-month return-27.4%
6-month return-13.3%
Stability (higher is calmer)Weak
14/100
Volatile, with deep drawdowns.
See the numbers →
Volatility, 1 year (lower is calmer)92.2%
Worst drawdown, 1 year (smaller is calmer)-49.8%
LiquidityWeak
16/100
Thinly traded: prices can jump and exits can be hard.
See the numbers →
Avg daily value traded0.02M USD
Zero-volume days0.0%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends0
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for UK when fundamentals data for this market is added. All UK stocks.
52-wk range 2.492 – 6.580Daily closes, split-adjusted
Signals
50-day average4.999
200-day average4.517
Golden/death cross (60d)None
New 52-week highNo
Bullish RSI divergenceYes
Average daily range (ATR)0.314
Technical summary
Daily
Bearish
2 bullish · 4 neutral · 9 bearish
Weekly
Strongly bearish
0 bullish · 1 neutral · 6 bearish
Monthly
Strongly bearish
0 bullish · 0 neutral · 1 bearish
Moving averages (daily)
SMA 10
3.63
Bullish
EMA 10
3.75
Bullish
SMA 20
3.84
Bearish
EMA 20
3.98
Bearish
SMA 50
5.00
Bearish
EMA 50
4.58
Bearish
SMA 100
5.14
Bearish
EMA 100
4.78
Bearish
SMA 200
4.52
Bearish
EMA 200
–
n/a
Oscillators (daily)
RSI (14)
42.21
Neutral
MACD (12, 26)
-0.36
Bearish
Momentum (12)
-2.20
Bearish
Stochastic %K (14)
78.24
Neutral
Williams %R (14)
-21.76
Neutral
CCI (20)
-27.84
Neutral
Pivot points (classic, last session)
S3
2.79
S2
3.06
S1
3.44
Pivot
3.71
R1
4.10
R2
4.37
R3
4.75
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Prices are end-of-day closes in USD. Educational only, not financial advice.
